Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Lulizumab pegol [USAN:INN]
RN: 1421830-13-8
UNII: LCT264LTYE

Note

  • Targets CD28.

Molecular Formula

  • C552-H859-N149-O164-S4.(C2-H4-O)n
 

Classification Code

  • Treatment of Autoimmune Disease
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Lulizumab pegol [USAN:INN]

Synonyms

  • BMS 931699
  • BMS-931699
  • Human immunoglobulin variable kappa chain, anti-(human T-cell-specific surface glycoprotein CD28 (TP44, CD28)), (70-(S-((3RS)-1-(3-((3-((2RS)-2,3-bis(gamma-methoxypoly(oxyethylene))propoxy)propyl)amino)-3-oxopropyl)-2,5-dioxopyrrolidin-3-yl)-L-cysteine))(IGKV1D-13*01 (84.3%) -IGKJ1*01) (6.3.8) (1-107) -Arg (108)
  • Lulizumab pegol
  • UNII-LCT264LTYE

Systematic Name

  • Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy-, 702,703-diether with immunoglobulin, anti-(human CD28 antigen) (70-(S-(1-(3-((3-(2,3-dihydroxypropoxy)propyl)amino)-3-oxopropyl)-2,5-dioxo-3-pyrrolidinyl)cysteine)) (synthetic human kappa-chain V region fragment)

Registry Numbers

CAS Registry Number

  • 1421830-13-8

FDA UNII

  • LCT264LTYE

System Generated Number

  • 1421830138